Sponsor Dossier
Lacuna Pharma
Sponsor Dossier for Lacuna Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: K-Citra
- Brand: Levocarnitine
- Brand: RUZURGI
- Brand: RYTHMODAN
About
Lacuna Pharma is an Australian Private Company with ABN 12646520792, registered in NSW. The company is active and registered for GST from 10 December 2020.
Portfolio
Lacuna Pharma has 4 brands on the ARTG, of which 2 are indexable and 2 carry a Product Information document. 2 brands are PBS-listed, 1 has a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include K-Citra, Levocarnitine, RUZURGI, RYTHMODAN.
Therapeutic focus
— Complementary Medicine: 1 brand — Cardiology: 1 brand — Renal: 1 brand — Neurology: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2022-03-01, across 1 brand with a PBAC outcome on record. The latest AusPAR is 2022-04-12, across 1 brand with an AusPAR on record.